Cannabis Suisse Corp. Reports No Revenue but Positive Net Income for November 2025 Quarter

Cannabis Suisse Corp. reported its financial results for the three and six months ended November 30, 2025, revealing a significant shift in its revenue and profitability compared to the previous fiscal period. The company generated no rental income during the current quarter, a decline from $7,500 in the same quarter of 2024, and similarly reported no revenue for the six-month period, down from $15,000 in the prior year. The absence of revenue is attributed to the termination of the company's only sub-lease in February 2025. Despite this, the company recorded a net income of $22,392 for the three months ended November 30, 2025, and a net income of $36,299 for the six months, a notable improvement from a net loss of $530,024 in the same period last year.

Operating expenses for the three months ended November 30, 2025, totaled $74,980, a decrease from $92,453 in the prior year. For the six-month period, operating expenses were $159,515, down from $167,436. The reduction in expenses is primarily due to a decrease in professional fees, which included a one-time charge in the previous year related to advisory fees for obtaining eligibility with the Depository Trust Company. The company’s general and administrative expenses increased, reflecting the lack of sublease revenue that previously offset some costs.

On the balance sheet, total assets decreased to $510,025 as of November 30, 2025, down from $635,075 at the end of the previous fiscal period. Current liabilities increased to $392,402, compared to $325,520 in May 2025, largely due to an increase in accrued interest and advances from related parties. The company’s stockholders’ deficit improved slightly to $(1,765,673) from $(1,801,972), reflecting the net income recorded during the period.

Strategically, Cannabis Suisse Corp. has focused on its real estate operations, having leased multiple properties from companies owned by its CEO. The company has not engaged in any activities related to the cannabis industry since June 2022. As of November 30, 2025, the company had cash of $2,625 and a working capital deficit of $316,580. Management has indicated that the company will continue to rely on related party funding and aims to raise additional capital to support its operations moving forward. The outlook remains cautious, with substantial doubt about the company's ability to continue as a going concern without securing further investment.